|  |
| |
| |
| |
| |
 |  |  |  |  |
    |
| PR:P46527-1 | cyclin-dependent kinase inhibitor 1B isoform 1 (human) | | |  | | |
 |  |  |  |  |  |
    |
| PR:000036634 | cyclin-dependent kinase inhibitor 1B isoform 1 phosphorylated 1 (human) | | |  | | |
 |  |  |  |  |  |
    |
| PR:000025750 | cyclin-dependent kinase inhibitor 1B isoform 1 phosphorylated 2 (human) | | |  | | |
 |  |  |  |  |  |
    |
| PR:000025752 | cyclin-dependent kinase inhibitor 1B isoform 1 phosphorylated 3 (human) | | |  | | |
 |  |  |  |  |  |
    |
| PR:000045370 | cyclin-dependent kinase inhibitor 1B isoform 1 unphosphorylated 2 (human) | | |  | | |
 |  |  |  |
    |
| PR:P46527 | cyclin-dependent kinase inhibitor 1B (human) | | |  | | |
 |  |  |  |  |
    |
| PR:P46527-1 | cyclin-dependent kinase inhibitor 1B isoform 1 (human) | | |  | | |
 |  |  |  |  |  |
    |
| PR:000036634 | cyclin-dependent kinase inhibitor 1B isoform 1 phosphorylated 1 (human) | | |  | | |
 |  |  |  |  |  |
    |
| PR:000025750 | cyclin-dependent kinase inhibitor 1B isoform 1 phosphorylated 2 (human) | | |  | | |
 |  |  |  |  |  |
    |
| PR:000025752 | cyclin-dependent kinase inhibitor 1B isoform 1 phosphorylated 3 (human) | | |  | | |
 |  |  |  |  |  |
    |
| PR:000045370 | cyclin-dependent kinase inhibitor 1B isoform 1 unphosphorylated 2 (human) | | |  | | |
| |
| |
 |  |  |  |  |
    |
| PR:P46527 | cyclin-dependent kinase inhibitor 1B (human) | | |  | | |
 |  |  |  |  |  |
    |
| PR:P46527-1 | cyclin-dependent kinase inhibitor 1B isoform 1 (human) | | |  | | |
 |  |  |  |  |  |  |
    |
| PR:000036634 | cyclin-dependent kinase inhibitor 1B isoform 1 phosphorylated 1 (human) | | |  | | |
 |  |  |  |  |  |  |
    |
| PR:000025750 | cyclin-dependent kinase inhibitor 1B isoform 1 phosphorylated 2 (human) | | |  | | |
 |  |  |  |  |  |  |
    |
| PR:000025752 | cyclin-dependent kinase inhibitor 1B isoform 1 phosphorylated 3 (human) | | |  | | |
 |  |  |  |  |  |  |
    |
| PR:000045370 | cyclin-dependent kinase inhibitor 1B isoform 1 unphosphorylated 2 (human) | | |  | | |